United States. Securities and Exchange Commission

United States. Securities and Exchange Commission

MannKind Corporation Enters into Commercial Supply Agreement with United Therapeutics Corporation

MannKind Corporation, a biopharmaceutical company based in Westlake Village, California, has entered into a commercial supply agreement with United Therapeutics Corporation, a biotechnology company focused on pulmonary arterial hypertension (PAH) and other diseases. This agreement marks a significant milestone for MannKind, as it will be responsible for manufacturing and supplying

United States. Securities and Exchange Commission

Ligand Pharmaceuticals Announces Positive Interim Results from Pivotal Phase 3 PROTECT Study of Sparsentan

Ligand Pharmaceuticals Incorporated, a biotechnology company, has announced positive topline interim results from the ongoing pivotal Phase 3 PROTECT Study of sparsentan, an investigational product candidate for the treatment of IgA nephropathy (IgAN). The study, conducted by Travere Therapeutics, Inc., met its pre-specified interim primary efficacy endpoint with statistical significance,

Information technology services industry

SpringWorks Therapeutics Expands Portfolio with Precision Medicine Approach and Shared-Value Partnerships

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that has successfully expanded its portfolio with a precision medicine approach and strategic partnerships. The company's differentiated portfolio of small molecule targeted oncology product candidates has enabled it to advance two potentially registrational clinical trials in rare tumor types, as well

Cybernet Data Systems Inc.

Bank of America Corporation Prospectus: Debt Securities, Preferred Stock, Depositary Shares, and Junior Subordinated Notes Offering

Bank of America Corporation has filed a prospectus for the offering of debt securities, preferred stock, depositary shares, and junior subordinated notes. The prospectus provides an overview of the securities being offered, including their terms and conditions. The bank has guaranteed the payment obligations of its finance subsidiaries, which have

Information technology services industry

Skyworks Solutions Completes Acquisition of Silicon Laboratories' Infrastructure and Automotive Business

Skyworks Solutions, Inc. has successfully completed its acquisition of Silicon Laboratories Inc.'s Infrastructure & Automotive business in an all-cash asset transaction valued at $2.75 billion. The acquisition expands Skyworks' global reach and diversifies its customer base, enabling the company to accelerate profitable growth in key industry